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‘‘Dermal Dendritic Cells’’ Comprise Two Distinct
Populations: CD1þ Dendritic Cells and CD209þ
Macrophages
Maria Teresa Ochoa1, Anya Loncaric1, Stephan R. Krutzik1, Todd C. Becker1 and Robert L. Modlin1,2,3
A key cell type of the resident skin immune system is the dendritic cell (DC), which in normal skin is located in
two distinct microanatomical compartments: Langerhans cells (LCs), mainly in the epidermis, and dermal DCs
(DDCs), in the dermis. Here, the lineage of DDCs was investigated using monoclonal antibodies and
immunohistology. We provide evidence that ‘‘DDC’’ comprise at least two major phenotypic populations of
dendritic-appearing cells, immature DC expressing CD1, CD11c and CD208; and macrophages expressing
CD209, CD206, CD163, and CD68. These data suggest that dermal dendritic-appearing macrophages comprise a
novel part of the innate immune response in the resident skin immune system.
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INTRODUCTION
The resident skin immune system functions to defend the host
against external threats, including microbial pathogens and
allergens, as well as physical assaults, including trauma and
UV light. The innate immune response is rapid, involving
cells expressing germline-encoded pattern-recognition recep-
tors, and has a role in directly dealing with the threat by
triggering microbicidal mechanisms, inflammation, and/or
apoptosis. Cells of the innate immune response include
keratinocytes, endothelial cells, Langerhans cells (LCs), and
dermal dendritic cells (DDCs). In contrast, the adaptive
immune response is slower in onset, involves receptors
clonally selected after gene rearrangement, results in
immunologic memory, and is mediated by T and B
lymphocytes.
A major skin-resident innate immune cell subset is the
‘‘DDC’’. Initially, DDCs were identified using a polyclonal
antibody against clotting factor XIIIa and thought to be a
homogeneous population (Cerio et al., 1988, 1989). As such,
they have been isolated from skin using various markers and
used in functional assays (Tse and Cooper, 1990; Meunier
et al., 1993; Nestle et al., 1993a; Duraiswamy et al., 1994).
Since DDCs are classified as DCs, they are presumed to be
professional antigen-presenting cells that have been recog-
nized as crucial regulators of cutaneous adaptive immune
response in humans and mice (Dupasquier et al., 2004).
However, the homogeneity and origin of these cells has
also been questioned (Adany et al., 1985, 1988; Muszbek
et al., 1985).
One of the problems in determining whether DDC
comprise a single homogeneous population or represent
two or more subsets has been the lack of specific markers.
We recently demonstrated that activation of Toll-like
receptors causes rapid differentiation of distinct precursors
of human peripheral monocytes into CD1bþ and CD209þ
(DC-SIGN) cells (Krutzik et al., 2005). CD1bþ cells had an
immature DC phenotype, release proinflammatory cytokines,
and function as efficient APCs. The CD209þ (DC-SIGN) cells
had a macrophage-like phenotype, were phagocytic, and
utilized CD209 to facilitate uptake of bacteria. These data
provide evidence that the dual host defense roles of the
innate immune system are mediated by induction of two
distinct phenotypic and functional populations, CD1bþ DCs
and CD209þ (DC-SIGN) macrophages. The surprising
finding was that CD209þ (DC-SIGN), which was previously
thought to be a marker for DCs (Geijtenbeek et al., 2000;
Engering et al., 2002), was found on a population of
macrophages in tonsil and inflamed skin. Using this
observation, we sought to investigate the phenotype of
various ‘‘DC’’ populations in the skin with monoclonal
antibodies that discriminate against DCs and macrophages,
using immunoperoxidase and confocal laser microscopy.
RESULTS
Identification of cells bearing DC markers in normal human skin
We investigated the in situ expression of different DC markers
(Table S1) in normal human skin tissue to determine their
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morphology, phenotype, and distribution (Figure 1). Cells
with a dendritic morphology were found in the epidermis and
dermis. CD1aþ and CD207þ (Langerin) cells, presumably
LCs, were located in the epidermis. Other DC markers,
including CD1b, CD1c, and CD11c, were found on
dendritic-appearing cells mainly in the superior dermis. We
also used markers for mature DC such as CD83 and CD208
(DC-LAMP); however, very few DCs expressing these markers
could be identified in normal skin.
Identification of cells expressing monocyte/macrophage
markers in normal human skin
The highest level of expression (that is, greatest frequency of
cells) using characteristic monocyte/macrophage markers
such as CD14, CD68, and CD163 (Table S1) was detected
in the dermis. Similar to DCs, cells bearing monocyte/
macrophage markers were also characterized by dendritic
morphology, and were located at the level of the capillaries
and in the higher part of the reticular dermis. The distribution
of CD209þ cells was similar to that of cells expressing CD14,
CD68, CD163, and CD206 (mannose receptor) (Figure 2).
DCs and macrophages in the dermis have similar morphology
Although DCs can be distinguished from monocytes/macro-
phages by their dendritic morphology, we found that
cells expressing characteristic macrophage markers can also
display a dendritic morphology (Figures 3 and 4a). The
morphology of the macrophages in the papillary and reticular
dermis ranged from elongated and spindled to compact and
stellate shape (Figure 4b).
Macrophage and DC markers are expressed on distinct subsets
of cells in normal human skin
To determine the phenotype of CD209þ (DC-SIGN) cells in
normal human skin tissue, frozen tissue sections were
labelled with antibodies to CD209 (DC-SIGN) and
paired with different DC and macrophage markers.
CD209þ (DC-SIGN) cells did not express CD207þ (Langer-
in), CD1a, CD1b, CD1c, CD11c, CD83, and CD208 (DC-
LAMP). These data indicate that CD209þ (DC-SIGN)
expression is not restricted to DCs in the skin (Figure 5a). In
addition, CD1bþ cells did not express macrophage markers
(CD163, CD68, and CD14), suggesting that CD1 expression
is restricted to DCs in the skin (Figure 5b).
We reasoned that CD209þ (DC-SIGN) and other mono-
cyte/macrophage markers might colocalize on cells in the
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Figure 1. Identification of DCs in normal human skin. Normal human skin
tissue was labeled with mAbs specific for CD207 (Langerin), CD1a, CD1b,
CD1c, CD83, CD208 (DC-LAMP), and CD11c, using the immunoperoxidase
method. Original magnification 200. Bars¼ 50mm.
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Figure 2. Identification of monocyte/macrophage cells in normal human
skin. Normal human skin tissue was labeled with mAbs specific for CD209
(DC-SIGN), CD206 (mannose receptor), CD163, CD14, CD16, and CD68,
using the immunoperoxidase method. Original magnification  200.
Bars¼ 50 mm.
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dermis of normal human skin. Therefore, expression of
CD209þ (DC-SIGN) and CD68, CD14, CD163, and
CD206þ (macrophage mannose receptor or MMR) was
examined in normal human skin tissue by immunofluores-
cence. A major population of dendritic-appearing cells was
located at the level of the capillaries and in the higher part of
the reticular dermis, and coexpressed CD209þ (DC-SIGN),
CD206þ (macrophage mannose receptor or MMR), and
monocyte/macrophage markers CD14, CD163, CD68, but
not DC markers (CD1a, CD1b, CD1c, CD11c, DC-LAMP,
and Langerin) (Figure 6).
Therefore, we conclude that CD209þ (DC-SIGN) macro-
phages, expressing CD68, CD14, and CD163, markers
typically found on monocytes/macrophages, comprise a
major subset of dendritic-appearing dermal cells.
Isolated dermal cells from normal human skin contain
CD209þCD11clo cells
To substantiate the immunohistological identification of
distinct populations of macrophages and DCs, dermal cells
were isolated from normal human skin and analyzed directly
by flow cytometry. Distinct populations of CD209þCD11clo
and CD209CD11chiþ cells were identified (Figure 7). These
data were obtained by separating epidermis from dermis, and
then dispersing cells in the dermis using a scalpel, which
resulted in low yield of mononuclear cells. Treatment of
the dermis with collagenase overnight, as described by
Zaba et al. (2007), resulted in loss of CD209 expression as
did treatment of peripheral blood-derived CD209þ cells
(data not shown). Loss of CD209 expression may be due to
dedifferentiation of macrophages during collagenase treat-
ment or due to proteolytic digestion of the CD209 epitope.
Therefore, additional technological considerations will be
required to obtain sufficient numbers of CD209þ cells from
normal skin for functional study.
DISCUSSION
The resident skin immune system stands guard to deal with
attacks from the outside environment, including microbes,
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Figure 3. Morphology and distribution of DC markers in normal human skin.
DC markers as CD207 (Langerin), CD1a, CD1b, CD1c, CD83, CD208 (DC-
LAMP), and CD11c were located in the epidermis and the superior dermis.
Original magnification  400. Bars¼ 50 mm.
CD209 CD206
CD68
CD163CD14
CD16
CD68 CD209
Figure 4. Morphology and distribution of monocyte/macrophage cell
markers in normal human skin. (a) Monocyte/macrophage cell markers such
as CD209 (DC-SIGN), CD206 (mannose receptor), CD163, CD14, CD16,
and CD68 were only located in the superior papillary and reticular dermis,
and not in the epidermis. Original magnification  400. Bars¼ 50mm.
(b) Monocyte/macrophage cells display dendritic morphology. Original
magnification  1,000. Bars¼ 5 mm.
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allergens and UV light. The epidermis serves as the initial
barrier; however, the resident immune cells in the dermis
must serve to deal with host threats that either escape
detection by the epidermis or enter via the cutaneous
vasculature. The dermal immune system is known to not
only involve circulating T cells that survey the skin for foreign
antigens, but also a population of ‘‘DDCs’’. Here, we provide
evidence that ‘‘DDCs’’ comprise at least two major pheno-
typic populations of dendritic-appearing cells, immature DCs
that express CD1, CD11c, and CD208, and macrophages that
express CD209, CD206, CD163, and CD68 (Figure 8). We
conclude that dermal dendritic-appearing macrophages are a
novel component of the skin immune system.
DDCs were initially identified and characterized using a
polyclonal antibody that recognizes clotting factor XIIIa. This
antibody was used to identify spindle- or stellate-shaped cells
in human connective tissue (Fear et al., 1984). Later, Reid
et al. (1986) called them fibroblasts. But it was Headington
(1986) who in 1986 named them ‘‘dermal dendrocytes’’—or
uncommitted stem cells—using a polyclonal antibody for
FXIIIa (Cerio et al., 1989). Unfortunately, factor XIIIa is not a
specific marker, as it can also be expressed on several cell
types, including endothelial cells (Suvarna and Cotton, 1993).
However, in 1987, using macrophage markers such as
RFD7, RFDR2 (HLA-DR), and KiM7 (CD68), Adany and
Langerin
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Figure 5. CD209þ (DC-SIGN) cells and DC markers are expressed on distinct subsets of cells in normal human skin. (a) Normal human skin tissue sections
were labeled with specific antibodies for DCs and visualized by confocal laser microscopy. CD209-positive cells (red images) did not colocalize with other DC
markers (CD207 (Langerin), CD1a, CD1b, CD1c, CD11c, CD208 (DC lamp)) (green images). (b) CD1bþ cells did not express monocyte/macrophage markers
(CD163, CD68, CD14). Nuclei were labeled with DAPI (blue images). Original magnification 400. Bars¼20 mm.
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Figure 6. CD209þ (DC-SIGN) cells and monocyte/macrophage cell markers
are expressed on the same subsets of cells in normal human skin. Normal
human skin tissue sections were labeled with specific antibodies for
monocyte/macrophage markers and visualized by confocal laser microscopy.
CD209 (DC-SIGN)-positive cells (red images) colocalize with other
monocyte/macrophage markers (CD206 (mannose receptor), CD163, CD68,
CD14) (green images). Nuclei were labeled with DAPI (blue images). Original
magnification 400 . Bars¼ 20 mm. The box in panel 2 and 3 indicates a
magnified positive cell.
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Muszbek (1987) (1989) suggested that these cells were tissue
macrophages. Functionally, DDCs demonstrate features of
both macrophages and DCs. A key macrophage function of
DDCs is their ability to efficiently phagocytose hemosiderin,
melanin, and bacteria (Altman et al., 1992; Filgueira et al.,
1996; Nestle et al., 1998). A key DC function of DDCs is their
ability to take up and process antigens, migrate to lymphatic
organs, and activate naı¨ve T cells (Nestle et al., 1993b; Nestle
and Nickoloff, 1995). Our data indicate that in fact resident
DDCs in normal skin are comprised of at least two
phenotypically distinct populations of CD209þ macrophages
and CD1þ DCs.
The CD209þ dermal dendritic-appearing macrophage
population is also present in inflamed skin, as we reported
in leprosy lesions (Krutzik et al., 2005). The phenotype of
these dermal dendritic-appearing macrophages includes
several markers of phagocytic function, CD209 (DC-SIGN),
CD206 (macrophage mannose receptor), and CD163
(Figure 5). Both CD209 and CD206 are pattern-recognition
receptors; CD209 (DC-SIGN) is a C-type lectin that binds
various glycoproteins and glycolipids (Geijtenbeek et al.,
2000; Ebner et al., 2004). CD209 has been shown to facilitate
the uptake of bacteria, including Mycobacterium tuberculosis,
and viruses, including HIV (Pohlmann et al., 2001).
CD206 (macrophage mannose receptor) is known to facilitate
uptake of microbial molecules containing a repeating
mannose motif (Sallusto et al., 1995; Wollenberg et al.,
2002). CD163 is the haptoglobin receptor involved in the
transport of iron into cells (Kristiansen et al., 2001). CD206
(mannose receptor) and CD11c (myeloid marker) can be
expressed in the two populations, DCs and macrophages,
as we previously reported (Krutzik et al., 2005). Together,
coexpression of these molecules indicates that dermal
dendritic-appearing macrophages are resident in normal
skin, and are likely to recognize microbial pathogens via
multiple pattern recognition receptors and phagocytose them.
This points the way to devise strategies to isolate these cells
from normal skin and study their function in vitro.
The function of dermal CD1þ DCs in terms of antigen
presentation activity has been demonstrated in earlier studies
(Meunier et al., 1993; Nestle et al., 1993a, b; Turville et al.,
2002). It has also been suggested that human LCs are
replenished by precursors in the dermis and that CD14þ
dermal APCs are the main precursor population (Larregina
et al., 2001). Further examination of leprosy skin lesions
using confocal laser microscopy revealed that distribution
and frequency of these resident skin populations might
correlate with disease status (Krutzik et al., 2005). Within
self-limited tuberculoid leprosy lesions, CD1aþ cells were
frequent in the epidermis, and CD209 (DC-SIGN) and CD1b
are expressed on distinct, non-overlapping dermal cell
populations. In contrast, within progressive lepromatous
leprosy lesions, the frequency of CD1aþ LCs and CD1bþ
dermal DCs was lesser. The CD209þ cells in tuberculoid
leprosy lesions were found to express monocyte/macrophage
markers CD14, CD16, CD64, and CD68, but did not express
DC markers CD1a, CD1b, CD63, CD83, or DC-LAMP. These
data indicate that the majority of CD209þ cells express cell-
surface markers typically found on monocytes/macrophages,
and reflect the phenotype found here in normal skin. Future
studies should be directed toward identifying the phenotype
of CD209þ cells in other disease states.
The studies by Zaba et al. (2007) support the presence of
distinct populations of macrophages and DCs in normal
human dermis, but differ in identifying the specific pheno-
typic of the dermal macrophages. Our study clearly identifies
a CD209þCD163þ macrophage population in normal skin
that do not express characteristic DC markers CD1a, CD1b,
CD1c, and DC-LAMP, in addition to CD11c. The restricted
expression of CD209 is of particular interest because it
mediates the phagocytosis of a range of microbial pathogens.
Zaba et al. demonstrated CD209 expression on both
macrophage and DC populations, but used fluorescence
microscopy for their analysis. Our studies used confocal
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Figure 7. Dermal cells isolated from normal human skin contain
CD209þCD11cloþ cells. Distinct populations of CD209þCD11clo and
CD209CD11chiþ cells were identified in dermal single-cell suspensions
from normal human skin.
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Figure 8. Subsets of DCs and macrophages in normal human skin. ‘‘DDCs’’
include at least two major populations of dendritic-appearing cells: immature
DCs that express CD1and CD208, and macrophages that express CD209,
CD163, CD14, and CD68.
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microscopy, which has the capability to analyze thin
(0.6–0.7 mm) optical sections that helps differentiate epitope
colocalization from cell overlap.
The mechanism by which these dermal DCs and macro-
phages differentiate from monocyte precursors is fundamen-
tal to understanding the resident skin immune system. We
previously demonstrated that human peripheral monocytes
activated with a Toll-like receptor 2/1 ligand were differ-
entiated into two distinct subsets: CD209þ CD16þ macro-
phages and CD1bþ CD209 DCs. CD209þ cells were
expanded by Toll-like receptor-mediated upregulation of
IL-15, had a macrophage-like phenotype, were phagocytic,
and used CD209þ to facilitate uptake of bacteria. In contrast,
CD1bþ DC were expanded by Toll-like receptor-mediated
upregulation of GM-CSF, promoted T-cell activation and
secreted proinflammatory cytokines. The mechanisms by
which these DDC and dendritic-appearing macrophages
accumulate in normal skin and disease lesions, as well as
their functional role in disease pathogenesis, should provide
new therapeutic targets for skin disease.
MATERIALS AND METHODS
Human normal skin tissue
Human normal skin tissue (obtained after breast reduction and
abdominal plastic surgery) from healthy volunteers was obtained
from the UCLA Tissue Procurement & Histology Core Laboratory
(HTLPC) at the UCLA School of Medicine. Acquisition of all skin
biopsy specimens from human donors was reviewed and approved
by the committees on investigations involving human subjects of the
University of California, Los Angeles, and adhered to the Declaration
of Helsinki Principles.
Biopsy specimens were embedded in OCT medium (Ames Co.,
Elkhart, IN) and snap-frozen in liquid nitrogen. Sections (4-mm thick)
were acetone-fixed and kept frozen (80 1C) until use.
Immunohistochemical studies of DC and monocytes/
macrophage expression in human normal skin tissue
Antibodies used for immunohistochemical studies are shown in
Table S1. Frozen tissue sections were blocked with normal horse
serum before incubation with the mAbs for 60 minutes, followed by
incubation with biotinylated horse anti-mouse IgG for 30 minutes.
Primary antibody was visualized using the ABC Elite system (Vector
Laboratories, Burlingame, CA), which uses avidin and a biotin-
peroxidase conjugate for signal amplification. The ABC reagent was
incubated for 30 minutes followed by addition of substrate (3-amino-
9-ethylcarbazole) for 10 minutes. Slides were counterstained with
hematoxylin and mounted in crystal mounting medium (Biomeda,
Foster City, CA).
Two-color immunofluorescence staining of cryostat sections
Double immunofluorescence was performed by serially incubating
cryostat tissue sections with mouse anti-human mAbs of different
isotypes (for example, O10 (anti-CD1a, IgG2a) and DCN46 (anti-
CD209, IgG2b)), followed by incubation with isotype-specific,
fluorochrome (A488) or (A568)-labelled goat anti-mouse immuno-
globulin antibodies (Molecular Probes, Carlsbad, CA). Controls
included staining with isotype-matched antibodies, as well as with
CD1a or CD209, followed by secondary antibodies mismatched to
the primary antibody isotype, to demonstrate the isotype specificity
of the secondary labeled antibodies. Images were obtained using
confocal laser microscopy. Nuclei was stained with 40,6-diamidino-
2-phenylindole (DAPI).
Confocal microscopy
Double immunofluorescence of normal skin sections was examined
using a Leica-TCS-SP MP inverted single confocal laser-scanning and
two-photon laser microscope (Heidelberg, Germany) fitted with
DPSS-diode (561 nm), argon (488 nm), and two-photon lasers
(Spectra-Physics Millenia, Mountain View, CA, X 532 diode pump
laser and Tsunami picosecond Ti-sapphire laser), at the Carol Moss
Spivak Cell Imaging Facility at the UCLA Brain Research Institute.
Sections were illuminated with 488 and 561 nm lasers for red and
green labels, and with Ti-sapphire laser set at 770 nm for DAPI
excitation. Images of specimens with Alexa-488, or Alexa-568,
(Molecular Probes), or DAPI were recorded sequentially through
spectral emission filters set from 500 to 550 nm for Alexa-488, from
580 to 700 nm for Alexa-568, and from 410 to 490 nm for DAPI.
Pairs of single images were superimposed for colocalization analysis.
All micrographs are compiled serial Z-stack images 1mm apart.
Isolation of dermal cells
Human normal skin was placed in cold RPMI and minced using two
scalpels until single cells were obtained. Non-specific staining was
blocked by incubating with non-specific mouse IgG for 10 minutes
in fluorescence-activated cell sorting buffer (phosphate-buffered
saline 0.1% sodium azide and 2% fetal bovine serum). Cells were
then incubated with fluorescently labeled primary antibodies
(CD209-FITC and CD11c-PE) (BD Biosciences, San Diego, CA).
Cells were washed two times before fixing in 1% paraformaldehyde.
Cells were then acquired using a FACSCalibur (BD Biosciences) in
the UCLA Flow Cytometry Core Facility. Data analysis was
performed using FlowJo software (Treestar, Ashland, OR).
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